Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery

Journal of Endovascular Therapy

Volumn 18, Issue 4, 2011, Pages 547-558

  Schwarzmaier D'Assie, Alexandra ^a   Nyolczas, Noemi ^b   Hemetsberger, Rayyan ^b   Strehblow, Christoph ^b   Matiasek, Johannes ^b   Farhan, Serdar ^c   Petrasi, Zsolt ^d   Huber, Kurt ^c   Wojta, Johann ^b   Glogar, Dietmar ^b   Plass, Christian ^b   Gyöngyösi, Mariann ^b   Karnik, Ronald ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Animal model; Bare metal stent; Drug eluting stent; Endovascular therapy; Internal carotid artery; Neointimal hyperplasia; Paclitaxel; Porcine model; Preclinical study

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN; PACLITAXEL; UNCLASSIFIED DRUG;

ANESTHESIA COMPLICATION; ANIMAL EXPERIMENT; ARTERY SPASM; ARTICLE; BALLOON DILATATION; BARE METAL STENT; BLEEDING; CAROTID ARTERIOGRAPHY; CAROTID ARTERY OBSTRUCTION; COMPARATIVE STUDY; DOMESTIC PIG; DRUG ELUTING STENT; ENTERITIS; EXTERNAL CAROTID ARTERY; FIBRIN DEPOSITION; FOLLOW UP; FRACTIONAL FLOW RESERVE; GENERAL ANESTHESIA; HISTOPATHOLOGY; HYPERPLASIA; IN-STENT RESTENOSIS; INFLAMMATION; INJURY; INTERNAL CAROTID ARTERY; MORPHOMETRICS; NEOINTIMA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; STENT THROMBOSIS; TREATMENT OUTCOME; VASCULAR NECROSIS;

ANGIOPLASTY, BALLOON; ANIMALS; CARDIOVASCULAR AGENTS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CELL PROLIFERATION; DRUG-ELUTING STENTS; HYPERPLASIA; METALS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; STENTS; SUS SCROFA; TIME FACTORS; TUNICA INTIMA;

EID: 80052302998     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/10-3347.1     Document Type: Article

References (41)

1. Zhu CZ, Norris JW. Role of carotid stenosis in ischemic stroke. Stroke. 1990;21:1131-1134. (Pubitemid 20255406)
2. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
3. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995;45:1488-1493.
4. Kasner SE, Chimowitz MI, Lynn MJ, et al. Warfarin Aspirin Symptomatic Intracranial Disease Trial. Circulation. 2006;113:555-563.
5. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325:445-453.
6. Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009;40:1999-1200.
7. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273:1421-1428.
8. Théron JG, Payelle GG, Coskun O, et al. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology. 1996;201:627-636.
9. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg. 1996;3:42-62. (Pubitemid 26066740)
10. Mas JL, Chatellier G, Beyssen B, et al. Endarter-ectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660-1671. (Pubitemid 44583956)
11. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7:893-902.
12. Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
13. International Carotid Stenting Study investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomized controlled trial. Lancet. 2010;375:985-997.
14. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
15. Gurm HS, Yadav JS, Fayad P, et al. SAPPHIRE Investigators. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358:1572-1579. (Pubitemid 351519817)
16. Bonati LH, Fraedrich G, Carotid Stenting Trialists' Collaboration. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis-a pooled analysis of EVA-3S, SPACE and ICSS. Eur J Vasc Endovasc Surg. 2011;41:153-158.
17. Hobson RW, Mackey WC, Ascher E, et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg. 2008;48:480-486. (Pubitemid 351997463)
18. Liapis CD, Bell PR, Mikhailidis D, et al. ESVS Guidelines - invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009;37:S1-S19.
19. Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ ASNR/CNS/ SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2011;57:e16-94.
20. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg. 2006;44:258-268. (Pubitemid 44142925)
21. SSYLVIA Study Investigators. Stenting of SYmptomatic atherosclerotic Lesions in the Vertebral and Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
22. Randall MS, McKevitt FM, Kumar S, et al. Longterm results of carotid artery stents to manage symptomatic carotid artery stenosis and factors that affect outcome. Circ Cardiovasc Interv. 2010; 3:50-56.
23. Tepe G, Muschick P, Laule M, et al. Prevention of carotid artery restenosis after sirolimuscoated stent implantation in pigs. Stroke. 2006;37:492-494. (Pubitemid 43732012)
24. Iancu A, Lazar A. Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting. J Invent Cardiol. 2007;19:275-279.
25. Qureshi AI, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drugeluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051. (Pubitemid 44852090)
26. Gupta R, Al-Ali F, Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37: 2562-2566. (Pubitemid 44454680)
27. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165-168.
28. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res. 2005;27:S95-102.
29. De Bruyne B, Bartunek J, Sys SU, et al. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation. 1995;92:93-96.
30. Piljs NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703-1708. (Pubitemid 26193622)
31. Piljs NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183-3193.
32. De Bruyne B, Piljs NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157-62. (Pubitemid 32655831)
33. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992; 19:267-274.
34. Schwartz RS, Henry TD. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med. 2002;3:S4-S9. (Pubitemid 36002153)
35. Schwartz RS, Edelman ER for the Consensus Committee. Drug-eluting stents in preclinical studies. Recommended evaluation from a Consensus Group. Circulation. 2002;106:1867-1873.
36. Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents: are human and animal studies comparable? Heart. 2003;89:133-138.
37. Kern R, Ringleb PA, Hacke W, et al. Stenting for carotid artery stenosis. Natural Clin Pract Cardiovasc Med. 2007;3:212-220. (Pubitemid 46613396)
38. Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg. 2004;100:688-694. (Pubitemid 38372851)
39. Levy EI, Hanel RA, Tio FO, et al. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180-day assessment. Neurosurgery. 2006;59:925-934.
40. Wieneke H, Dirsch O, Sawitowski T, et al. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv. 2003;60:399-407. (Pubitemid 37356512)
41. ACCF/SCAI/SVMB/SIR/ASITIN 2007. Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2007; 49:126-170.